Exocad GmbH recalls exoplan version 3.1 Rijeka Software -A medical software, intended to support the pre-operative planning of dental impla…
- Recall date
- August 17, 2023
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2633-2023
- FDA classification
- Class II
- Brand / firm
- Exocad GmbH
- Sold / distributed
- Worldwide distribution - US Nationwide and the country of Canada.
Why it was recalled
A software library filtering error has been discovered which occurs when users are using the Step-by-Step Full Drill Protocol export functionality of exoplan 3.1 Rijeka. When a guided surgery treatment approach is selected, along with a Step-by-Step Full Drill Protocol export implant library, exoplan software does not filter out unsupported sleeve height positions for a particular sub-full drill protocol and instead shows ALL possible sleeve height positions for all sub-full drill protocols. The use of an improper sleeve height position in a surgical guide could result in patient injury
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
exoplan version 3.1 Rijeka Software -A medical software, intended to support the pre-operative planning of dental implants using the visualization of the implant placement within images of the patents anatomy.
Get recall alerts
Free email alert whenever Exocad GmbH has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Exocad GmbH